Skip to main content
Premium Trial:

Request an Annual Quote

Allegro Wins NCI Grant for Lung Cancer Dx

NEW YORK (GenomeWeb News) – Allegro Diagnostics has won up to $2.8 million in funding from the National Cancer Institute for clinical studies of its BronchoGen, a molecular diagnostic test for early-stage lung cancer.

The company said today that it will use the Phase I and II Fast Track Small Business Innovation Research funding for a study that will enroll up to 800 patients in 12 sites in the US.

"The grant will accelerate Allegro Diagnostics' current clinical trial aimed at validating BronchoGen as an early lung cancer diagnostic tool and will assist in developing a series of additional genomic tests that could help lessen the human toll of the leading cause of cancer death in the US and the world," Allegro Diagnostics CSO and Co-founder Jerome Brody said in a statement.

The BronchoGen test analyzes RNA to measure gene expression levels using epithelial cells that were taken during bronchoscopy. The company said it has found that specific sets of genes are over-and under-expressed in current and former smokers with lung cancer compared to those without lung cancer, a finding it said was validated through a 164-patient study.

Bronchoscopy, which is performed over 300,000 times per year in the US, has a low sensitivity for detecting disease and would benefit from follow-up diagnostics when it is not conclusive, the company said. The BronchoGen test would not require that an actual tissue sample be removed from a suspicious nodule or lesion, it added.

"The development of technologies that can aid in the accurate diagnosis of lung cancer based on analysis of (bronchial) samples is likely to result in less discomfort to patients and may help bring down costs associated with diagnostic testing," NCI Program Director Ali Andalibi said.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.